Copyright
©The Author(s) 2019.
World J Gastroenterol. Nov 14, 2019; 25(42): 6322-6341
Published online Nov 14, 2019. doi: 10.3748/wjg.v25.i42.6322
Published online Nov 14, 2019. doi: 10.3748/wjg.v25.i42.6322
Figure 6 MicroRNAs in correlation to ligand independent c-Met activation and progression of hepatocellular carcinoma in type 2 diabetes mellitus patients.
HCC: Hepatocellular carcinoma; miRNA: MicroRNA; NAFLD: Nonalcoholic fatty liver disease; T2DM: Type 2 diabetes mellitus.
- Citation: Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. World J Gastroenterol 2019; 25(42): 6322-6341
- URL: https://www.wjgnet.com/1007-9327/full/v25/i42/6322.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i42.6322